Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan W Riess

Showing results (31-40 of 132) with videos related to

Pageof 14
Sort By:
Clinical Lung Cancer|May 16, 2019
Immune Checkpoint Inhibitor-Induced Myasthenia Gravis in a Patient with Advanced NSCLC and Remote History of ThymomaMatthew S Lara, Alaa Afify, Michael P Ellis, et al.
Clinical Lung Cancer|April 12, 2025
Genetic Ancestry and Lung Cancer in Latin American Patients: A Crucial Step for Understanding a Diverse PopulationJuan Pablo Castañeda-González, Rafael Parra-Medina, Jonathan W Riess, et al.
Lung Cancer (Amsterdam, Netherlands)|December 3, 2014
Pemetrexed in patients with thymic malignancies previously treated with chemotherapyYing Liang, Sukhmani K Padda, Jonathan W Riess, et al.
Clinical Lung Cancer|August 1, 2024
Current Trial Report: A Multicenter Phase I/Ib study of Capmatinib Plus Trametinib in Patients With Metastatic Nonsmall Cell Lung Center Harboring MET Exon 14 Skipping Mutations and Other MET-AlterationsMatthew S Lara, Jonathan W Riess, Jonathan W Goldman, et al.
Clinical Lung Cancer|September 14, 2022
A Case of Osimertinib-Induced Eosinophilic PneumoniaKanishka G Patel, Rebecca L Corbett, Zarir E Karanjawala, et al.
Clinical Lung Cancer|January 26, 2019
EBV-positive Primary Pulmonary Lymphoepithelioma-like Carcinoma Response to PD-L1 BlockadeAnand Narayanan, Friedrich D Knollmann, Julie Ann S Walby, et al.
Lung Cancer (Amsterdam, Netherlands)|July 8, 2015
Dovitinib and erlotinib in patients with metastatic non-small cell lung cancer: A drug-drug interactionMillie Das, Sukhmani K Padda, Adam Frymoyer, et al.
The Oncologist|March 16, 2018
Weekly Docetaxel, Cisplatin, and Cetuximab in Palliative Treatment of Patients with Squamous Cell Carcinoma of the Head and NeckVanessa Trieu, Harlan Pinto, Jonathan W Riess, et al.
Anticancer Research|February 11, 2015
GLI1, CTNNB1 and NOTCH1 protein expression in a thymic epithelial malignancy tissue microarrayJonathan W Riess, Robert West, Michelle Dean, et al.
JTO Clinical and Research Reports|September 10, 2025
Older Adult Participation in Early-Phase Lung Cancer Clinical Trials, 1998 to 2020Desirae Ehley, Lilit Vardanyan, Rebecca S Boxer, et al.
Pageof 14

Showing results (31-40 of 132) with videos related to

Sort By:
Pageof 14
Clinical Lung Cancer|May 16, 2019
Immune Checkpoint Inhibitor-Induced Myasthenia Gravis in a Patient with Advanced NSCLC and Remote History of ThymomaMatthew S Lara, Alaa Afify, Michael P Ellis, et al.
Clinical Lung Cancer|April 12, 2025
Genetic Ancestry and Lung Cancer in Latin American Patients: A Crucial Step for Understanding a Diverse PopulationJuan Pablo Castañeda-González, Rafael Parra-Medina, Jonathan W Riess, et al.
Lung Cancer (Amsterdam, Netherlands)|December 3, 2014
Pemetrexed in patients with thymic malignancies previously treated with chemotherapyYing Liang, Sukhmani K Padda, Jonathan W Riess, et al.
Clinical Lung Cancer|August 1, 2024
Current Trial Report: A Multicenter Phase I/Ib study of Capmatinib Plus Trametinib in Patients With Metastatic Nonsmall Cell Lung Center Harboring MET Exon 14 Skipping Mutations and Other MET-AlterationsMatthew S Lara, Jonathan W Riess, Jonathan W Goldman, et al.
Clinical Lung Cancer|September 14, 2022
A Case of Osimertinib-Induced Eosinophilic PneumoniaKanishka G Patel, Rebecca L Corbett, Zarir E Karanjawala, et al.
Clinical Lung Cancer|January 26, 2019
EBV-positive Primary Pulmonary Lymphoepithelioma-like Carcinoma Response to PD-L1 BlockadeAnand Narayanan, Friedrich D Knollmann, Julie Ann S Walby, et al.
Lung Cancer (Amsterdam, Netherlands)|July 8, 2015
Dovitinib and erlotinib in patients with metastatic non-small cell lung cancer: A drug-drug interactionMillie Das, Sukhmani K Padda, Adam Frymoyer, et al.
The Oncologist|March 16, 2018
Weekly Docetaxel, Cisplatin, and Cetuximab in Palliative Treatment of Patients with Squamous Cell Carcinoma of the Head and NeckVanessa Trieu, Harlan Pinto, Jonathan W Riess, et al.
Anticancer Research|February 11, 2015
GLI1, CTNNB1 and NOTCH1 protein expression in a thymic epithelial malignancy tissue microarrayJonathan W Riess, Robert West, Michelle Dean, et al.
JTO Clinical and Research Reports|September 10, 2025
Older Adult Participation in Early-Phase Lung Cancer Clinical Trials, 1998 to 2020Desirae Ehley, Lilit Vardanyan, Rebecca S Boxer, et al.
Pageof 14